Skip to main content

Failed clinical trials

A series of reviews focusing on the importance of learning from failed Alzheimer’s disease clinical trials and a number of measures that may accelerate drug development against the disease.

  1. In a slowly progressive disorder like Alzheimer disease, evaluation of the clinical effect of novel drug candidates requires large numbers of patients and extended treatment periods. Current cell- and animal-b...

    Authors: Henrik Zetterberg, Niklas Mattsson, Kaj Blennow and Bob Olsson
    Citation: Alzheimer's Research & Therapy 2010 2:32